July 1, 2026
Apnimed Announces Publication of its Phase 3 SynAIRgy Trial of AD109 for Obstructive Sleep Apnea in the American Journal of Respiratory and Critical Care Medicine
B Companion mechanistic review article published concurrently in the American Journal of Respiratory Cell and Molecular Biology in first-of-its-kind dual publications Publications reinforce AD109’s potential,…
